BREAKING NEWS
Ton-up Jaiswal takes India to 275/1 at lunch against Australia on day 3 of opening Test
Centre meeting floor leaders of political parties on Sunday ahead of Parliament Session
COP29: India rejects new USD 300 billion climate finance deal
AR Rahman sends notice to ‘slanderers’ over speculations surrounding separation with Saira Banu
Jaiswal’s Perth Simulation: 200 overs in 2 days, inclined concrete slab, lighter synthetic balls
Maharashtra poll results unexpected, incomprehensible: Uddhav Thackeray
BJP snatches one Lok Sabha seat from Congress; Maharashtra win boosts Rajya Sabha majority prospects
PCB says no meeting with ICC, BCCI officials on November 26 to resolve CT imbroglio
Maharashtra victory a win for development, says PM Modi, congratulates JMM alliance in Jharkhand
Royal tour of India in offing for King Charles, Queen Camilla: Report
TMC hits a six: Sweeps by-polls, snatches one from BJP; RG Kar protests fail to impact voters
Not many takers for NOTA in these assembly polls too
Look forward to being your voice in Parliament: Priyanka to people of Wayanad
Pant may go for higher than Rs 25 crore, owners would not want to miss his X-factor: Raina
None of Adani portfolio cos subject to any legal case: Group CFO on promoter indictment in US
Singapore-based firm to start human trials for Covid-19 treatment
Team Udayavani, Jun 12, 2020, 11:02 AM IST
Tychan, Singaporean biotechnology firm, will begin human clinical trials next week for a potential monoclonal antibody treatment for Covid-19
The first phase of the trial will be conducted on healthy volunteers to determine the safety and tolerability of TY027, a monoclonal antibody or immune system protein that specifically targets the virus that causes Covid-19.
TY027 is being explored for its ability to slow down the progression of Covid-19 and speed up recovery, and its potential to provide temporary protection against infection
It is said that if phase one is successful, Tychan will seek approval for the antibody to be administered to a larger population of volunteer patients in subsequent trials.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
COP29: India rejects new USD 300 billion climate finance deal
Royal tour of India in offing for King Charles, Queen Camilla: Report
Indian-American leaders applaud PM Modi for inclusive growth in India
COP29: Civil society protests climate finance proposal, calls for ‘no deal’ over ‘bad deal’
Bomb disposal squad tackles ‘security incident’ at UK’s Gatwick Airport
MUST WATCH
Latest Additions
Will collectively introspect ‘shocking’ drubbing in Maharashtra polls, says Congress
Ton-up Jaiswal takes India to 275/1 at lunch against Australia on day 3 of opening Test
Ton-up Jaiswal takes India to 275/1 at lunch against Australia on day 3 of opening Test
Cong’s performance shocking, worst-ever in Maharashtra polls: Prithviraj Chavan
Mcap of 8 of top-10 most-valued domestic firms jumps Rs 1.55 lakh cr; HDFC Bank, TCS sparkle
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.